Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sibutramine versus sibutramine + topiramate for weight loss in obese adults
RBR-106bgs3cPhase 4Terminated
- Sponsor
- Santa Casa de Misericórdia de São Paulo
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sibutramine and topiramate in obesity and Overweight (2 arms), sponsored by Santa Casa de Misericórdia de São Paulo. Started Nov 2024; status: terminated.
02
Drugs
sibutraminetopiramate
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on RBR-106bgs3c.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-106bgs3c.